ABOUT OUR ATTORNEYS
The law firm of Douglas & London, P.C. provides legal services to clients injured by acts of negligence and medical malpractice. Whether through settlement, verdict, or mediation, our entire legal team fights to maximize recovery for each of our clients.
World Trade Center Exposure attorneys Gary Douglas and Michael London, as well as team of other attorneys and support staff in our office, share a fundamental belief in the rights of the underdog and will fight any wrongdoer, no matter how big. Whether we are taking on governmental entities, the pharmaceutical industry, tobacco industry, automobile industry, or an individual doctor who failed to properly diagnose a patient, Douglas & London handles and prepares every case the same - to its fullest potential.
Michael A. London
Michael A. London, the firm's founding partner, was born in New York City, received a Bachelor of Arts at the University of Miami, in Coral Gables, Florida, and a Juris Doctorate from Brooklyn Law School in New York. He is admitted and licensed to practice law in both the state of New York and the state of New Jersey. In addition, he is admitted to practice in federal courts in both New York and New Jersey, as well as the Court of Federal Claims in Washington, D.C. Mr. London has been admitted pro hac vice in over 12 state and federal courts across the country. He has also been appointed to and served on multiple plaintiff steering committees and as class counsel.
Mr. London was formerly a partner at the Law Offices of Sybil Shainwald, a firm focusing on women’s health law. Throughout his career, he has been committed to representing injury victims, primarily in mass tort settings. Mr. London consistently focuses on products liability litigation with an emphasis in pharmaceutical litigation. He also handles some general negligence cases, environmental toxic tort cases, and complex medical malpractice cases in New York State and across the country.
Mr. London has secured millions of dollars in settlements for persons injured by harmful drugs like Zyprexa®, where Mr. London served as the Vice Chairman of the Plaintiff's Steering Committee responsible for negotiating a $690 million Dollar settlement. He has obtained over $75 million in settlements and verdicts for persons injured by harmful drugs including: Zyprexa®, Ortho Evra®, DES, silicone breast implants, Norplant®, defective insulin pumps, Accutane®, as well as numerous vaccines, and other drugs and medical devices.
In January 2004, Mr. London and his partner Gary J. Douglas, Esq., secured a verdict of over $20 million for the widow of a former smoker in the first successful personal injury tobacco lawsuit in the State of New York. Mr. London was also co-trial counsel in the very first Norplant® products liability trial in the State of New York - shortly after the verdict in his trial, a national settlement of over $50 million was reached.
As noted above, Mr. London has been appointed to and served on multiple steering committees and as class counsel. He was most-recently appointed to the Plaintiffs’ Steering Committee in the Ortho Evra Birth Control Patch Products Liability litigation, and then appointed by the same judge to serve as the Court’s federal liaison counsel. He was also appointed Vice-Chair of the Plaintiffs' Steering Committee in the In re: Zyprexa® Products Liability Litigation, MDL-1596. He was co-class counsel in a national class action against Colgate® Oral Pharmaceuticals for certain forms of toothpaste and oral rinse that contain an ingredient that has been shown to cause pre-cancerous lesions in the mouth. He was appointed to the Objectors' Steering Committee to represent individual smokers with personal injury claims against Liggett & Myers in its proposed class action to settle all of its pending cases which he and others defeated because of its failure to provide adequate compensation to present, future and foreign Class members. He was co-counsel in the first national Thimerosal class action alleging that exposure to Thimerosal in certain vaccines causes autism and other neurological disorders in children, and was thereafter appointed to the Plaintiffs' Steering Committee to litigate these cases before the Court of Federal Claims.
His former pharmaceutical litigation experience included active participation in the silicone breast implant litigation, including both the MDL-926 and the Dow Corning® bankruptcy proceeding, where his former law firm held Steering Committee roles in both forums, and represented all foreign women, including in a global settlement for all foreign women who received silicone beast implants manufactured by companies other than Dow Corning®. Mr. London participated and litigated the Parlodel drug products liability cases from inception through the first trial which resulted in a successful confidential award to the plaintiff's widow and family, and also actively represented injured clients across the country with defective Telectronics pace maker leads, the Dalkon Shield IUD, and the Copper-7 IUD, all to the benefit of his clients.
Michael A. London is an active member in many legal associations. He serves on the board of directors of the New York State Trial Lawyers Association (NYSTLA); the Association of Trial Lawyers of America (ATLA), where he also serves as the federal state liaison to the Zyprexa Litigation Group; the New York State Bar Association (NYSBA); and the Tobacco Trial Lawyers Association (TTLA). Mr. London has lectured to attorneys on such topics as medical malpractice, jury selection in products liability cases, and jury selection in tobacco cases, and has been invited to assist the Brooklyn Law School's Moot Court Trial Team on multiple occasions.
Mr. London has also appeared on CNN, Dateline, MSNBC, as well as other local news programs and he has also appeared in the New York Times, and in virtually every other local New York paper along with many other publications across the country. Additionally, he has written numerous articles for publication in legal journals on various topics, including vaccine use, the Learned Intermediary Doctrine, the Harvard University Medical Malpractice Study, jury selection in products liability cases, mercury exposure, youth smoking, and light cigarettes litigation.
Gary J. Douglas
Gary J. Douglas, a founding partner, was born in New York City and is the firm's senior trial attorney. In his 18 plus year career, Mr. Douglas has become a nationally renowned courtroom fighter having scored more than 25 verdicts and settlements in excess of One Million Dollars, including historical verdicts against the tobacco, automobile and pharmaceutical industries.
Throughout his career, Mr. Douglas has protected the rights of people injured by defective products, medical malpractice, and general negligence. Known for his unorthodox and dramatic courtroom style, Mr. Douglas is never afraid to take on the giant corporations, giving a voice to the voiceless victims of corporate malfeasance.
As a trailblazer in the field of products liability, Gary Douglas scored the first victory in the nation against an automobile manufacturer for a defective airbag resulting in the death of a 6-year-old boy. He followed that with the first victory in the history of the State of New York against the Tobacco Industry, securing a verdict of $20 Million for the death of a 58-year-old smoker.
Some of Mr. Douglas' other remarkable results include a $21 million verdict for a 16-year-old teen struck by a New York City Subway train and a $5 million verdict for a construction worker who lost vision in one eye from a chemical burn, and there are many others. See our firm’s verdicts and settlements for more of Mr. Douglas' spectacular courtroom results. Mr. Douglas is a one of New York's most respected and most feared trial attorneys. He routinely appears in the New York Jury Verdict Reporter for the impressive verdicts and the settlements he secures for his clients.
In addition to filing suit against the manufacturers of the Ortho Evra® birth control patch, attorneys Gary J. Douglas and Michael A. London have spearheaded litigation against other major drug manufacturers. The firm’s recent involvement in Zyprexa® product liability litigation helped to yield a $690 million settlement.
Mr. Douglas has been quoted in newspapers across the country and has appeared on many local and national television broadcasts for his results, including CNN's Burden of Proof.
He currently serves on the Executive Committee for the Board of Directors of the New York State Trial Lawyers Association.
Mr. Douglas obtained a Bachelor of Arts Degree from the State University at Albany, and obtained his Juris Doctor Degree from The Jacob Fuchsberg Law Center of Touro College in New York. He is an active member of numerous legal associations, including the New York State Trial Lawyers Association (NYSTLA) and the Association of Trial Lawyers of America (ATLA).
Mr. Douglas, a former partner and senior trial attorney at Finz & Finz, where he represented injured plaintiffs, began his legal career and honed his trial skills at the nationally acclaimed Wall Street medical malpractice defense firm of Leahey & Johnson.